Given that elevated IL-36R signaling is linked to intestinal inflammation and fibrosis (Scheibe et al, 2019), it can be hypothesized that the identified mutations might at least partially contribute to the pathogenesis of CD in those patients by leading to an increased IL-36R signaling activity due to a reduced expression of IL-36RA. The gene discussed is IL1RL2; the disease is Cowden disease.